Video

Mark Levy, FRCGP: Digital Inhaler Increases Treatment Adherence

Author(s):

In a new study presented at ERS 2020, Dr. Mark Levy discusses how a digital inhaler reduces the amount of people who use their inhaler incorrectly.

Inhaler use can be difficult for some asthma patients, leading to faulty adherence and improper dosing of medications.

However, with the advent of new technology, it might soon be easier to know when an inhaler is being improperly used so that the problems can ultimately be corrected.

In a poster presented at the European Respiratory Society International Congress 2020 (ERS 2020), researchers presented data testing a new digital inhaler that alerts the user through a smartphone application whether or not they are using the inhaler correctly.

By promoting better inhaler techniques, the researchers believe ultimately they can severely reduce the amount of preventable asthma hospitalizations and improve care for the disease.

In the 696 patient study, the investigators found the digital inhaler helped identify patterns of use and provided clinically meaningful information early and facilitated physician-patient interventions and conversations.

In an interview with HCPLive®, Mark L. Levy, FRCGP, discusses why patients seem to struggle with inhalers and how digitalizing the technology could have a drastic impact on reducing asthma hospitalizations.

Levy explained how inhaler technique has long been an issue for asthma patients and that many of the asthma issues ultimately could have been prevented.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.